Variable | Present study (n=159) | WEAVE/WOVEN (n=152) | P value |
Age, mean±SD | 59.4±9.5 | 61.9±10.5 | – |
Female, n (%) | 39 (24.5%) | 71 (46.7%) | <0.001 |
Hypertension, n (%) | 110 (69.2%) | 140 (92.1%) | <0.001 |
Diabetes mellitus, n (%) | 53 (33.3%) | 91 (59.9%) | <0.001 |
Hyperlipidemia, n (%) | 60 (37.7%) | 131 (86.2%) | <0.001 |
Smoking, n (%) | 0.004 | ||
Current smoker | 45 (28.3%) | 21 (13.8%) | |
Previous smoker | 43 (27.0%) | 59 (38.8%) | |
Never smoked | 71 (44.7%) | 72 (47.4%) | |
BMI, mean±SD | 25.66±3.14 | 30.93±7.03 | – |
Lesion distribution | <0.001 | ||
Anterior circulation | 63 (39.6%) | 102 (65.0%) | |
Posterior circulation | 96 (60.4%) | 55 (35.0%) | |
Target artery distribution | <0.001 | ||
ICA | 25 (15.7%) | 40 (25.5%) | |
MCA | 38 (23.9%) | 62 (39.5%) | |
VA | 48 (30.2%) | 32 (20.4%) | |
BA | 48 (30.2%) | 22 (14.0%) | |
PCA | 0 (0.0%) | 1 (0.6%) | |
Qualifying ischemic events | <0.001 | ||
TIA | 75 (47.2%) | 0 (0.0%) | |
Ischemic stroke | 84 (52.8%) | 152 (100.0%) | |
Qualifying events on the basis of antiplatelet therapy, n (%) | 75 (47.2%) | – | – |
Time to stent from qualifying event (days), median (IQR) | 20 (9–34) | 22 | – |
Baseline NIHSS, median (IQR) | 0 (0–2) | – | – |
Baseline mRS, n (%) | <0.001 | ||
0 | 96 (60.4%) | 20 (13.2%) | |
1 | 48 (30.2%) | 37 (24.3%) | |
2 | 15 (9.4%) | 52 (34.2%) | |
3 | 0 (0.0%) | 43 (28.3%) |
BA, basilar artery; BMI, body mass index; ICA, internal carotid artery; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery; TIA, transient ischemic attack; VA, vertebral artery.